Breadcrumb

Company Statements

Daiichi Sankyo Europe's Statement Regarding Esperion Therapeutics' Complaint
$DownloadTitle.getData()

Industry Veteran, Dr. Mark Rutstein, Joins Daiichi Sankyo to Lead Global Oncology Clinical Development Program
View Resource


Daiichi Sankyo, Inc. has taken measures to contribute to the overall effort to limit the spread of the virus that causes COVID-19.
$DownloadTitle.getData()